ProCE Banner Activity

Antibody–Drug Conjugates, Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma

Slideset

Downloadable slideset from a live webinar covering the latest safety and efficacy data for antibody–drug conjugates, bispecific antibodies, and CAR T-Cell therapies in the management of relapsed/refractory multiple myeloma

Released: July 24, 2024

Expiration: July 23, 2025

Share

Faculty

Noopur Raje

Noopur Raje, MD

Professor of Medicine
Harvard Medical School
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi